- Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study
-
Nam CW, Kim DS, Li J, Baccara-Dinet MT, Li I, Kim JH, Kim CJ
- KMID: 2463483
- Korean J Intern Med.
- 2019 Nov;34(6):1252-1262.
- doi: 10.3904/kjim.2018.133
BACKGROUND/AIMS: Efficacy and safety data of alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9), is not yet well established in the Korean population. We assessed... -
- CITED
-
- Close
- SHARE
-
- Close
